AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 71 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,193,050 | -20.9% | 603,762 | 0.0% | 18.42% | +4.3% |
| Q2 2023 | $10,354,518 | -15.0% | 603,762 | 0.0% | 17.66% | -27.3% |
| Q1 2023 | $12,177,880 | -31.2% | 603,762 | 0.0% | 24.30% | -15.8% |
| Q4 2022 | $17,690,227 | +76.7% | 603,762 | 0.0% | 28.88% | +85.3% |
| Q3 2022 | $10,010,000 | +6.1% | 603,762 | 0.0% | 15.59% | +20.0% |
| Q2 2022 | $9,437,000 | -14.7% | 603,762 | 0.0% | 12.99% | +54.1% |
| Q1 2022 | $11,067,000 | +55.5% | 603,762 | 0.0% | 8.43% | +162.7% |
| Q4 2021 | $7,118,000 | – | 603,762 | – | 3.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |